Prescription Drug Coverage and Medicare Spending among U.S. Elderly

被引:3
|
作者
Shang, Baoping [1 ]
Goldman, Dana [2 ]
机构
[1] Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA
[2] Univ So Calif, Sch Policy Planning & Dev, Los Angeles, CA 90089 USA
关键词
prescription drugs; health insurance benefits; adverse selection; health care spending; HEALTH-CARE SERVICES; ADVERSE SELECTION; INSURANCE-COVERAGE; PHARMACY BENEFITS; MEDIGAP INSURANCE; COST-CONTAINMENT; IMPACT; COPAYMENT; OUTCOMES; REFORM;
D O I
10.1057/gpp.2010.21
中图分类号
F8 [财政、金融];
学科分类号
0202 ;
摘要
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly. Of paramount importance-often unaccounted for in budget estimates-are the salutary effects that increased prescription drug use might have on other Medicare spending. This paper uses longitudinal data from the Medicare Current Beneficiary Survey to estimate how prescription drug benefits affect Medicare spending. We compare spending and service use for Medigap enrollees with and without drug coverage. Owing to concerns about selection, we use variation in supply-side regulations of the individual insurance market-including guaranteed issue and community rating-as instruments for prescription drug coverage. We employ a discrete factor model to control for individual-level heterogeneity that might induce bias in the effects of drug coverage. We find Medigap prescription drug coverage significantly increases drug spending and reduces Medicare Part A spending. Medigap prescription drug coverage reduces Medicare Part B spending, but the estimates are not statistically significant. Furthermore, the substitution effect decreases as income rises, and thus provides support for the low-income assistance program of Medicare Part D. The Geneva Papers (2010) 35, 539-567. doi:10.1057/gpp.2010.21
引用
收藏
页码:539 / 567
页数:29
相关论文
共 50 条
  • [41] Growth in prescription drug spending among insured elders
    Thomas, CP
    Ritter, G
    Wallack, SS
    [J]. HEALTH AFFAIRS, 2001, 20 (05) : 265 - 277
  • [42] National Health Spending In 2014: Faster Growth Driven By Coverage Expansion And Prescription Drug Spending
    Martin, Anne B.
    Hartman, Micah
    Benson, Joseph
    Catlin, Aaron
    [J]. HEALTH AFFAIRS, 2016, 35 (01) : 150 - 160
  • [43] Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019
    Dusetzina, Stacie B.
    Huskamp, Haiden A.
    Qin, Xuanzi
    Keating, Nancy L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (15): : 1515 - 1522
  • [44] Prescription drug spending for beneficiaries in the last Medicare plus Choice year of life
    Fahlman, Cheryl
    Lynn, Joanne
    Doberman, Danielle
    Gabel, Jon
    Finch, Mike
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2006, 9 (04) : 884 - 893
  • [45] Heart Failure Prescription Drug Spending and Medical Costs in Medicare Part D
    McGee, Blake T.
    Parikh, Rishika
    Phillips, Victoria
    [J]. CIRCULATION, 2019, 140
  • [46] ASSESSMENT OF MEDICARE ADVANTAGE PRESCRIPTION DRUG COVERAGE GAP AMONG COPD PATIENTS: ANALYSIS OF HOSPITALIZATION USE
    Bhansali, A.
    Sansgiry, S. S.
    Serna, O.
    Fleming, M. L.
    Abughosh, S.
    Kamdar, M.
    Stanford, R.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A120 - A120
  • [47] Moral hazard and prescription drug use among non-institutionalized elderly Medicare beneficiaries
    Gajria, KL
    Pyles, MA
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 300 - 300
  • [48] Medicare Part D: Early evidence on prescription drug treatment patterns, hospitalization offsets and medicare spending
    Zhang, Y.
    Newhouse, J. P.
    Hanlon, J.
    Lave, J.
    Donohue, J. M.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A5 - A5
  • [49] The impact of medicare part D on prescription drug use by the elderly
    Lichtenberg, Frank R.
    Sun, Shawn X.
    [J]. HEALTH AFFAIRS, 2007, 26 (06) : 1735 - 1744
  • [50] Medicare prescription drug coverage gap - Navigating the "doughnut hole" with patients
    Berkowitz, Scott A.
    Gerstenblith, Gary
    Anderson, Gerard F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (08): : 868 - 870